Literacy demands of product information intended to supplement television direct-to-consumer prescription drug advertisements

Patient Education and Counseling

Volumn 55, Issue 2, 2004, Pages 293-300

  Kaphingst, Kimberly A ^a,d   Rudd, Rima E ^a   DeJong, William ^b   Daltroy, Lawren H ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Direct to consumer advertising; Literacy; Readability; Suitability; United States Food and Drug Administration

Indexed keywords

ARTICLE; DRUG APPROVAL; DRUG INFORMATION; DRUG LABELING; DRUG MARKETING; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE PERSONNEL; PRESCRIPTION; PRIORITY JOURNAL; SMOG; TELEVISION;

ADVERTISING; BOSTON; DRUG INDUSTRY; DRUG INFORMATION SERVICES; DRUG LABELING; EDUCATIONAL STATUS; GUIDELINE ADHERENCE; GUIDELINES; HUMANS; INFORMATION DISSEMINATION; INTERNET; MASS MEDIA; PAMPHLETS; PATIENT EDUCATION; PERIODICALS; PRESCRIPTIONS, DRUG; TELEVISION; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 7644240647     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pec.2003.11.003     Document Type: Article

References (31)

1. Miller C. Drug firms boost pitch directly to consumers. Marketing News. 28:1994;1
2. Schommer J.C., Doucette W.R., Mehta B.H. Rote learning after exposure to a direct-to-consumer television advertisement for a prescription drug. Clin. Ther. 20:1998;617-632
3. Frank RG, Berndt ER, Donohue JM, Epstein AM, Rosenthal MB. Trends in direct-to-consumer advertising of prescription drugs. Menlo Park, CA: Kaiser Family Foundation; 2002.
4. Rosenthal M.B., Berndt E.R., Donohue J.M., Frank R.G., Epstein A.M. Promotion of prescription drugs to consumers. N. Engl. J. Med. 346:2002;498-505
5. Nordenberg T. Direct to you: TV drug ads that make sense. FDA Consumer. 32:1998;7-10
6. Baylor-Henry M., Drezin N.A. Regulation of prescription drug promotion: direct-to-consumer advertising. Clin. Ther. 20:1998;C86-C95
7. Talley C.R. Direct-to-consumer prescription drug advertising. Am. J. Health Syst. Pharm. 54:1997;2181
8. Bradley L.R., Zito J.M. Direct-to-consumer prescription drug advertising. Med. Care. 35:1997;86-92
9. US Food and Drug Administration. FDA to review standards for all direct-to-consumer Rx drug promotion. http://www.fda.gov/bbs/topics/NEWS/ NEW00582.html; accessed 14 December 2002.
10. US Food and Drug Administration. Guidance for industry, consumer-directed broadcast advertisements. http://www.fda.gov/cder/guidance/index.htm; accessed 14 December 2002.
11. Kessler D.A., Pines W.L. The federal regulation of prescription drug advertising and promotion. J. Am. Med. Assoc. 264:1990;2409-2415
12. Wilkes M.S., Bell R.A., Kravitz R.L. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff. 19:2000;110-128
13. Roth M.S. Patterns in direct-to-consumer prescription drug print advertising and their public policy implications. J. Public Policy Marketing. 15:1996;63-75
14. Bell R.A., Wilkes M.S., Kravitz R.L. The educational value of consumer-targeted prescription drug print advertising. J. Fam. Pract. 49:2000;1092-1098
15. Consumer reports. Drug advertising: is this good medicine? Consumer Rep 1996;61:62-3.
16. Kirsch IS, Jungeblut A, Jenkins L, Kolstad A. Adult literacy in America: a first look at the results of the national adult literacy survey. Washington, DC: National Center for Education Statistics, US Department of Education; 1993.
17. Kaphingst KA, DeJong W, Rudd RE, Daltroy LH. A content analysis of direct-to-consumer television prescription drug advertisements. Under review.
18. Klare GR. Readability. In: Pearson PD, Barr R, Kamil ML, Mosenthal P, editors. Handbook of reading research. New York: Longman; 1984. p. 681-744.
19. Meade C.D., Smith C.F. Readability formulas: cautions and criteria. Pat. Educ. Couns. 17:1991;153-158
20. Pichert J.W., Elam P. Readability formulas may mislead you. Pat. Educ. Couns. 7:1985;181-191
21. Doak CC, Doak LG, Root JH. Teaching patients with low literacy skills. 2nd ed. Philadelphia: J.B. Lippincott Company; 1996.
22. Root J., Stableford S. Easy-to-read consumer communications: a missing link in Medicaid managed care. J. Health Polit. Policy Law. 24:1999;1-26
23. Fry E. Fry's readability graph: clarifications, validity, and extensions to level 17. J. Reading. 21:1977;242-252
24. Hochhauser M. Which prescription for the illegible and unreadable DTC brief summary - major surgery or euthanasia? Managed Care Q. 10:2002;6-10
25. Basara L.R., Juergens J.P. Patient Package Insert readability and design. Am. Pharm. NS34:1994;48-53
26. Morris L.A., Myers A., Thilman D.G. Application of the readability concept to patient-oriented drug information. Am. J. Hosp. Pharm. 37:1980;1504-1509
27. McLaughlin G. SMOG grading - a new readability formula. J. Reading. 12:1969;639-646
28. Krass I., Svarstad B.L., Bultman D. Using alternative methodologies for evaluating patient medication leaflets. Pat. Educ. Couns. 47:2002;29-35
29. National Institute for Health Care Management Research and Educational Foundation. Prescription drug expenditures in 2001: another year of escalating costs. Washington, DC: National Institute for Health Care Management Foundation; 2002.
30. Federal Food, Drug, and Cosmetic Act. Public Law 87-781, 21CFR202.1, Section 502(n).
31. US Food and Drug Administration. Guidance for industry: using FDA-approved patient labeling in consumer-directed print advertisements. http://www.fda.gov/cder/guidance/4114dft.htm; accessed 11 August 2003.